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UV irradiation induces a variety of cutaneous re-
sponses, including disruption of epidennal pertne-
ability barrier function, the basis for which is not 
known. Herein, we investigated the separate roles of 
hyperproliferation and inflatntnation in the patho-
genesis of UVB-induced barrier disruption. Adult 
hairless tnice were exposed to increasing doses of 
UVB (1.5-7.5 MED), and transepidertnal water loss 
(TEWL) was tnonitored daily for up to 7 d. The extent 
of TEWL increase was dependent on the UVB dose, 
but with all doses, the increase began after ;::::48 hand 
peaked at 96 h, decreasing by 120 h. Epidertnal 
eH]thytnidine incorporation increased at 24 hand 
peaked at 48 h (570%), preceding the tnaxitnal in-
crease in TEWL. Cyclosporin A, tnethotrexate, 5-flu-
oro uracil, or arabinosylcytosine significantly ditnin-
ished the UVB-induced TEWL increase. Athytnic 
nude tnice also displayed a tnarkedly ditninished 
response to UVB, and DNA synthesis did not in-
U ltrav iolet irradiation (UVR) of m ammalian skin indu ces a va riety of well -docum ented acute re-sponses, including erythem a, hyperproliferation, d~.sq ~l ~mation , and p~r.m eabiJi~y barriel: altera tions. DII11II1lshed permeabIli ty barrier funcbon also h as 
been reported in response to ultravio let B (UVB; Abe and M ayu-
zumi, 1979; Lamaud and Schalla, 1984; Haratake et ai, 1997); 
combined ul travio let A and U VB (Bronaugh and Stewart, 1985; 
Bissett e/ ai, 1987); o r ul travio let C (Solomon and Lowe, 1979). 
UVR of either human (McAuliffe and Blank, 1991) o r rat 
(Brona ugh and Stewart, 1985) skin also results in increased percu-
taneo us absorption of xenobiotics. Altho ugh these studies dem on-
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creased at 48 h. Transplantation of athytnic tnice with 
T-cell-enriched tnixed itntnune cells significantly re-
stored sensitivity to both the UVB-induced hyperpro-
liferation and the barrier defect. Finally, although 
UVB exposure increased PGEz levels in whole skin 
satnples (2- to 3-fold within 1-3 h; p < 0.005) , this 
increase was cotnpletely blocked b y topical indo-
tnethacin, and neither topical indotnethacin nor top-
ical glucocorticoids blocked developtnent of the bar-
rier abnortnality. These results show that (i) UVB 
produces delayed alteration in barrier function and 
(ii) both an epidertnal proliferative response and 
thytnocyte-tnediated events (but not PGEz produc-
tion and nonspecific infiatnlnation) appear to con-
tribute to UVB-induced abrogation of the pertneabil-
ity barrier. Key lVol,ds: epiderma1 p ermeability 1)a ft/'ier/DNA 
sJllltllesislT cellslathymic. ] l,west D el'lllatoi 108:769-775, 
1997 
strate that UVR can comprom.ise permeabiliry barrier function , th e 
responsible m echanisms are not known. 
T h e UVR-induced b arrier abnormality displays important inher-
en t diflirences £i·om other m o dels of barrier abrogation. Organic 
solvents, surfacta nts, and tape stripping cause an immediate barrie r 
defect due to rem oval of eXb·acellular lipids fi·om the stratum 
corneum (Menon et ai, 1985). T hese insults in turn , stimulate the 
release of sti ll only partially defined signaling molecules (Lee et ai, 
1992; Wood et ai, 1992; Nickoloff and Naidu, 1994; Lio u e/ ai, 
1997) that initiate a rapid repai.r response. T he repair sequen ce 
includes a burst in b o th epidermal lipid (Menon ef ai, 1985; 
Holleran ct ai , 1991 a, 1991b; Proksch el ai, 1991 a) and DNA 
synthesis (Proksch e/ ai, 1991b), w hich leads to a rap id restoration 
of barrier function. In contrast, UVR stimulates the generation of a 
number of effector molecules immediately after exposure, in cluding 
a £1 mily of epidermal cytokines (Kupper el ai, 1987; Oxl101m e/ al. 
1988; Schwarz and Luger, 1989; Ko ndo ct ai, 1994) and 
prostaglandins (B lack c/ ai, 1978, 1980), initiating a compl ex 
cutaneous resp o nse. T hese m ediators initiate both an inflamma-
tory respon se, i n cl uding e ryth ema and epiderm al h yp erplasia 
(Epstein e/ ai, 1968, 1970) . T h e d elayed UVR-induced barri e r 
abnorma li ty occurs within this setting of ep id erm al hyperplasia 
and cu ta neous inflammation . In this study, we explored the 
sepa rate ro les of epid ermal hyperpla sia and selected compo nents 
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of the inflammatory response on the development of the barrier 
abnormality after UVB exposure. 
MATERIALS AND METHODS 
Animals HaitIcss (Skh: hr-1), BALB/c, and athymic (BALB/c nude 
Th - /Th - ) male mice, 6-8 wk old, were purchased from Japan SLC 
(Shizuoka, Japan), Charles River Japan (Kanagawa, Japan) , and Charles 
River U .S.A. (Hollister, CAl. Mice were fed CE-2 (Clea Japan, Tokyo, 
Japan) or Purina mouse diet (Ralston Purina, St. Louis, MO) and water nd 
libitlllll. Natural sll!1light was excluded and animals were exposed only to 
low levels of incan.descent light. 
UV Irradiation Twelve fluorescent sun lamp tubes (Toshjba FL 20SE, 
Toshiba Electric, Tokyo, Japan) were used as the source of UVR. These 
tubes emit wave lengths between 280 11m and 340 nm, with a peak of 305 
nm. The dorsal skin of mouse was irradiated with single UV dose equivalent 
to 1.5, 3.0, 4.5, 6.0, or 7.5 times the minimal erythemal dose (MED). 
corresponding to 0.03, 0.06, 0.09 0.12 or 0.15 J per cm2 , respectively, as 
quantitated with a UV-R'ldiometer (UVR-305/365D II , Topcon, Tokyo, 
Japan). Higher doses were not studied, as significant increases in transcpi-
dermal water loss (TEWL) were evident at 0.15 ] per cmz, and this dose 
corresponds to relevant UVB exposure in hum'lIls. 
Drug Applications Arabinosylcytosinc (AraC; Sigma, St. Louis, MO), 
cyclosporin A (CsA, Sandoz Phannaceuticals, Vienna, Ausrria), or metbo-
trexate (MTX; Lederle Japan, Tokyo, Japan) in sterile saline was injected 
[AraC and MTX, 1.0 I11g intraperitolleally (IP); CsA, 0.3 or 3.0 mg [PJ 
within 15 l11in , and at 24 and 48 h aftcr UVR. 5-Fluorouraci l (2.5 mg; in 
white vaseline, topically) (Tok-yo C hemjcal Industry, Tokyo, Japan). indo-
methacin farnesi l (Esai, Tokyo, Japan), a pro-drug of indomethacin [0.50 
mg in propylene glycol:ethallol, 7:3 (vol/vol); Sigma, St. Louis, MOj, or 
hydrocortisone (0.5 mg of either 1 % tI'iamcinolone cre<1lu Or 1 % cortico-
sterone: Sigma, St. Louis, MO) were applied topically immediately after 
UVB expom ... " and daily for 4 d thereatter . To acltieve optimal inhibition of 
cycJooxygenase, topical indomethacln pre-treatment also was applied once 
daily for 2-5 d prior to UVB . 
Assessment of Barrier Function TEWL was measured on the dorsal 
surface of hairless mice both before and at various time points after UVB 
irradiation , b)' using a Hidrograph AMU-3 (Foushon, Nagoya, Japan). Data 
are expressed as milligrams pe r centimeter squared per hour (mean :t SEM). 
Assessment of Epidermal Hyperplasia Whole skin sections were 
fixed in formalin 'Uld sta ined with hematoxylin and eosin. Epidermal 
truckness was quantitared on photographs of hematoxylin-and-eosin-
stained sections, with a micrometer (0.01 111m, Nikon , Tokyo, Japan) a,;d a 
light microscopic photograph system (XF-311UFX-Il, Nikon, Tokyo, 
Japan) . The epidermal thickness waS assessed digitally in each photograph 
(Digitalmatic; Mitutoyo, Japan) and the average (:t SEM) of 10 Skill section 
sices (in micrometen) is reported. 
Epidermal Proliferation Epidenn,1I DNA synthesis was assessed at 0, 1, 
3,6.12, 24,36,48,60,72,84,96 , and 120 h after UVB irradiation by using 
the incorporation of CHjchj'lt1iciine (30 /-tCi of (metil),i-3H)thymidine given 
IP) (40 - 60 Cilmmol; ICN Radiochemicals, Costa Mesa, CAl into DNA 
according to the method ofProksch el ni (1991b). Epidermis was separated 
from dermis after incubation in phosphate-buffered saEne (pH 7.4; 60°C) 
for 45 s. For incorporation studies in athymic animals, skin samples were 
excised, the subcutaneous fat was removed by gentle scraping with a scalpe l 
blade, and sampJes were placed detn"lis-side down On keratinocyte growth 
medium (37°C) comaining 20 )LCi of[3 H]chymidine for 1 h. DNA contenr 
was detennined by using the diphellylall1i"e reagent (LaB'lrca and l'nigen, 
1980). DNA synthesis was expressed as disintegrations per mimlte incor-
porated per milligram of DNA per hour (mean :t SEM) . 
T-Cell-Enriched Immune-Cell Transplantation in Athymic Ani-
mals Whole thymus, spleen, and l)'mph nodes were removed from 
hairl ess (or BALB/c) thymocyte-competent animals 24 h after UVR. 
Tissues were gro und gently over wire mesh , and co llected cells were 
cultured ill standard thymocyte medium (RPM! 1640 medium containing 
10% fetal bovine serum) containing phytohemagglutinin (5 f..!,g per 1111; 
Seikagaku, Tokyo, Japan) to promote thymocyte mitogencsis, as described 
(Kruisbeek and Shevach , 1993). The T-cell-enriched mixed immune cells 
were harvested, cells were sedimcnted by ccntrifugation (200 X g), washed 
twice with sterile phosphate-buffered saline (0.9% NaCI) , suspended in 
sterile phosphate-buffered sa line, and injected Il) into recipient athymic 
animals (5 X 107 cell s pCI' anima l). Animals were UVB-irradiated immedi-
ately prior to transplantation, and barrier function was assessed by me"sur-
ing TEWL at various times (0, 48, 72 , 96, and 120 h) after irradiation. 
Results are expressed as the change in TE\VL (ratio of TEWL at time .\' 
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Figure 1. Changes in barrier function (TEWL) of hairless mice. 
after UVB irradiation. The fold change in TEWL (i.e., ratio of post-
irradiation to pre-irradiation TEWL) measured for each animal ,It' '-SlIS time 
after irradiation . Values are avcrage of duplicate animals (11 ~ 4 measure'-
ments per animal). The dorsal skin of mouse W;IS irr:ldiated (time 0) with a 
single dose of 1.5,3.0,4.5,6.0, or 7.5 MED (equiv;llem dose in] per CQ1~ 
also shown). Baselillc TEWL wa.51.0S l11g per cm 2 per h; error bars for each 
va lue (SD < 5%) were omitted for clarity. 
perslI, time 0; mean ± SEM). Contl'ols included hairless mice treated with 
UVB alone and 1l011-UV-irradiated nthymic animals that received crans-
plants of the "lmc immune-cell preparations. 
Cutaneous Prostaglandin £ . (PGE2) Determinations Whole-skin 
samples from inadiated and Ilonirradiated animals were scraped with a 
scalpel blade to remove subcutaneous fat and immediately homogenized ill 
ethanol (- 20°C) with a Polytron tissue homogenizer (20 s) under nitrogen 
gas. PGEz waS purified by octadecylsilyl silica column chrolll'ltography as 
described (Powell , 1980) . PGEz levels were then determined by using the 
PGE2 radioimmunoassay sys tel11 (Amershall'l, Arlington Heights, Il). 
Statistical Analysis Scatistical significances were detcJ"ll1.ined using a 
two-tailed Student's t test. 
RESULTS 
UVB Induces a Transient Dose-Dependent Barrier Abnor-
mality We first examined the titne- and dose-dependent effects 
of UVB on epidermal barrier function in hairless mice. A single 
UVB exposure induced an increase TEWL in a dose- and time-
dependent manner (Fig 1). Although no significant changes in 
TEWL occurred during the tirst 48 h after any UVB dose, by 72 h 
TEWL was elevated significantly in mice irradiated with a dose 
greater than 4.5 MED (0.09 J per cm2 ; p :$ 0.01) . In addition, the 
extent of elevation of TEWL was dependent upon the energy of 
irradiation, with the maximal observed inctease occurring with 7.5 
MED. With all UVB doses of 24.5 MED, TEWL levels peaked al 
96 h, declining by 120 h, and by 168 h TEWL levels had returned 
to normal (data not shown). These studies sho w that the barrier 
response to UVB in hairl ess mouse skin is dose-dependent, delayed, 
and transient. 
Increased DNA Synthesis and Epidermal Hyperplasia Pre~ 
cede Development of the UVB-Indllced Barrier Abnormal-
ity Prior studies have shown that acute UVB exposure increases 
epidermal DNA synthesis le<lding to epidermal hyperplasia (Epstein 
et nl, 1968, 1970). To delineate the relationship between the 
UVB-induced barrier abnonnality and epidermal hyperprolifer. -
tion, we next assessed epidermal DNA synthesis at various time; 
after the highest dose ofUVB (7.5 MED). Immediately after UVll 
irradiation (0-8 h) , epidermal DNA synthesis decreased in com· 
parison to DNA synthesis rates in untreated murine epidermis (Fig 
2). By 36 h, however, eH)thymidine in corporation increased 
significantly, peaking at 48 h with levels = 5.7-fold higher than 
pre-irradiation values, decreasing rapidly toward pre-irradiatioll 
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Figure 2. Effect of UVB irradiation 011 epidermal DNA synthesis . 
DNA synthesis was estimated in hairl ess mouse epidermis by using the ratio 
of [3H]thymidine incorporation after UVB to that in nonirradi ated control 
animals. The dorsa l skin of mouse was irradiated with single dose (0.15 J per 
cm2 ) a t 0 time. Values are the average fo r two animals (triplicate determi-
nations). Base li ne inco rporation is 86.5 ± 15.6 disintegrations per minute 
per JLg of DNA per h. 
val ues over the next 24-48 h . Histologic analysis showed that the 
UVB-induced stimulation o f DNA synthesis leads to epidermal 
hyperplasia by 48 h , with further epidermal thickening by 72 11 (Fig 
3) . Digital assessm ent also demonstrated a signifi cant increase in 
epid ermal thickness with time after UVB [i. e ., pre-UVB (baseline). 
27.9 ± 0.7 /1-111 ; 48 h after UVB, 52.5 ± 1.0 /1-m (p < 0.00 1 vcrs liS 
baseline); 72 h after UVB , 58. 1 ± 0.6 /1-m (p < 0.00 1 /lerSlls 
base line)]. Finally, a comparison of the kiJl e tics of the increase 
DNA synthesis with the changes ill TEWL demonstrates that the 
increase in DNA synthesis precedes development of the barrier 
abnorm ali ty (compare Figs 1 and 2) . 
Inhibitors of Epidermal Proliferation Blunt the UVB-In-
duced Barrier Alteration Since the results above sugges t that 
UVB-induced hyperproliferation might provoke the barrier abnor-
mality, we next asked whether co- administration of inhibitors of 
epidennal proliferation would diminish the UVB-induced barrier 
alteration. AraC, administered immediately after UVB exposure, 
significantly inhibited the UVB-induced increase in TEWL; i. e., 
SA- fold verslis lA- fold increase in UVB + vehicle and UVB + 
AraC, respectively (Table I) (p ::; 0.01; 72 h) . Moreover, AraC 
significantly inhibited the UVB- induced increase in eHlthymidine 
incorporation [i. e., non-UVB control epidermis, 92 ± 15 disinte-
grations per minute per /1-g of DNA per h ; UVB + vehicle 
UVB AB R OGATION OF EPIDERMAL PEI~EABILlTY BARRJER 771 
Table I. Inhibitors of DNA Synthesis Diminish the 
UVB-Induced Barrier Defect 
Fold Increase in TEWL" 
72 h after UVB 96 h after UVB 
Vehicle Drug Vehicle Drug 
Compound Treated Treated Treated Treated 
Ara C 5.39 ± 0.8 1.42 ± 0.6 5.86 ± 0.7 3.47 ± 0.5 
(p s 0.01)" (p s 0.05) 
MTX 3 .7 ± 1.1 1.49 ± 0.2 9 .06 ± 0.6 3.33 ± 0.5 
(p s 0.01) (p s 0.01) 
5FU 5.96 ± 1.0 2.6 ± 0.4 5.12 ± 0.7 3.87 ± 0.7 
(p s 0.01) (p = NS), 
II Fold increase in TE\ VL (irradiatcd/ n on-irradi:1tcd controls; mean ± SEM ; (n ~ 3 
;\I1imals for each). 
10 Significnllce (drug-treated versus vchicle-treated control). 
( NS. 110[ significant. 
epidermis. 548 ± 130 (p < 0.05 verslls non-UVB control); UVB + 
AraC-treated epidermis, 267 ± 41 disintegra tions per minute per 
f.lg of DNA per h (p < 0.05 verslls UVB-treated). Furthermore, two 
other chemically unrelated DNA s)'llthesis inhibitors, 5- fluorouracil 
and MTX, also diminished the barrier defect induced by UVE 
irradiation at 72 and 96 h after co-administration of each drug Witll 
UVB (Table I) . These results show that drugs that inhibit epider-
mal hyperproliferation also attenuate the UVB-induced banier 
abnormality. 
T Cells Participate in the UVB-Induced Barrier Defect 
Because inhibitors of epidermal DNA synthesis only partially 
abrogate the UVB-induced defect in barrier fimction, we next 
asked whether components of the inflammatory response also 
contribute to the barrier abnormali ty. We next investigated 
whether treatment witl1 cyclosporin A, an anti-inflalrunatory agent 
with potent activ ity against cytokine production by T cells 
(Granelli-Piperno, 1988; Schwarz and Luger, 1989), keratinocytes 
(Won ef nl, 1994), and whole mouse skin (Kono el nl, 1995) , 
diminishes the UVE-induced barrier defect. Whereas a low dose of 
CsA (0 .3 m g IP) immediately after U V expOSUl'e did not attenuate 
the subsequent barrier abnormality, a higher CsA dose (3.0 m g IP) 
nearly eliminated the subsequent UVB-induced barrier abnormali ty 
(Fig 4). This CsA dose also diminished the UVB-induced epider-
mal hyperplasia response (data not shown) . In addition, CsA alone 
had no effect on permeability barrier function in nonirradi ated 
animals (data not shown) . 
We next assessed the involvem ent of T cells in the UVB 
response more directly by investigating the ability of comparable 
Figu.re 3. Hcnlatoxylin and cosin staining ofhairlcss mice skin section. The dorsal skin of mouse was irradiated with single dose (0.15 J per cm 2) . 
Sections fi'om mOllse skin taken at O. 48 . and 72 h after irradiation. respectively. arc as indicated. Srtlic bar, 5.7 I.un . 
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Figure 4. CsA iuhibits the UVB-induced barrier abrogation. Hair-
less mice were trca ted with UVB (0.15 J per cm' ) as above, followed 
immediately by the injection of vehicle (saline) or low- (0.3 mg) or 
high-dose (3 .0 mg) CsA JP. Values arc fi'om " represenrative experiment. 
Baseline TEWL was :1.08 mg per em 2 pCI' h. Low-dose CsA ( . ) did not 
alter tile UVB-barrier e!fect ("erslIs control ; 0 ). High-dose CsA (0 ) 
eliminated the barrier-disruptive effects oC UVB at aU time points (I' :$ 
0.001). E/'/'O/' bnrs, SEM (II 2: 4). 
doses ofUV13 to indu ce a barrier abnormali ty in athymic nude mice 
lJerSIIS age- and sex-matched T - cell-replete hail'less mice. All 
animals were irradia ted with the high est dose of UVB (7.5 ME D) 
employed in these studies, and the permeability barri er function 
was m easured over time, as described above (see Pig 1) . In contrast 
to the T-ceU-rep lete contro ls, athymic mice did no t develop a 
significant barrie r defect afte r UVE exposure (Fig SA) . T hese 
resu lts are consistent with in volvem ent of one compo nent of the 
inAaI11matoryliI11l11une response (i. e., T cells) in the UVB-induced 
barrier defect. 
To de te rmjne further whether the decreased UVB sensitivity of 
athymic animals w as due to their lack of T cells, we replenish ed 
athymic animals w ith T -cell- enrich ed l11ixed immune cells ob-
t~ined fi'om UV-trea ted donor anim als (see iVIa fcr;a{s a/ld !l1ethods). 
Ath ymic animals th at received these mixed immun e cells developed 
a barri er abnormali ty after UVB exposure, comparable to the defect 
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in control immunocompetent animals (Fig SB l/CJ'SIIS A). In addi-
tion , cells from ' all ogen eic (h airless) (Fig 5B) and syn geneic 
(BALB/c) (data n ot sh own) donor mice were equally eifective in 
restoring the barrier response i.n athymic anjmals. Furthermore, the 
barrie r alteration could not be attributed to the all ografted mixed 
iml11une cells alone, because injection of these cells, fro m either 
UV - o r non-UVB- treated animals, alone into normal con trol 
animals did no t induce a barrier defec t . T hese results show that T 
cells are like ly contdbutors to the UVB-induced barrier abnormal-
ity. 
We next de termined w h e ther irradiation of donor 3Jlim als \Va 
r equired for reconstitution of the UVB-barrier defect. Mixed 
immune cells fi'om donor (hairl ess) an imals, previou sly exposed co 
UVE , w ere again able to re- es tablish the UV-indu ced barrier defeec 
in athymic [ulimals (Fig 6) . Cen s from no n-UVB-irradiated donor , 
h owever , did n ot support the development of the barrier abnor-
mality (Fig 6). T hese results dem onstrate that a process ofiml11uJ1e-
cell ac tivation by UVB appears necessary for the pathogenesis of the 
UVB-barrie r defect. The la ck of effectiven ess b y the non-UVE-
[rea ted donor cells dem onstra tes that the phytohemagglu tinin 
exposure itself, during the m ixed immun e cell expansion ill lI;rl'O, is 
insu/l'i cient to r epli cate the barrier dismptive e fFe ct. In add ition, 
conditio ned medium obtained from UVE-treated donor cells did 
not restore the barrier resp on se in athYll1ic animals (data not 
shown), indicating tbat a soluble facto r produced during ;11 J1;rro 
T-cell expan sion is not responsibl e for the restorative effects. 
Additi onal studies will be required to de termine w hether phytohe-
magglutinin exposure of donor cells from UVB-tteated animals is 
necessary for t he reconstitution effect(s). 
Because epidermal hyperp ro li fe ration also appears to be an 
important component of the UVB-indu ced p athogen esis, w e inve '-
tigated th e DNA synthetic response in athymic Jler.IJ.IS hairles 
control animal epidermis. Whereas epidermal DNA synthesis rates 
w ere com parabl e in athymic l/erSIlS immunocompetent hairless mice 
under basal conditions, th e increase in epide rmal DNA synthesi . 
w h.i ch occurs in hairless controls 48 h afte r UVB , was significantly 
diminished in athymic epidermis; i .e., thymidine incorporation 
increased 2.4-fold J1erSJIs 1.1-fold in control JlerSIlS athymic epider-
nus, respectively (Table 1I; p .$ 0.001). Furth ermore, rep lerusb-
l11ent of athymic animals with T-cell- enrich ed mixed immun e cell 
signi fican tly increased the epide rmal DNA synthe tic response to 
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Figure 5. UVB docs not induce barrier defect in athymic nude mice. (AJ Control (hrlhr) and athymic nude (BALB) mice were treated \Vim 
equivalent UVB doses (0.15 J per em' ). The increase in TEWL observed in hairless T-cell- competent animals (D ) was significantly attenuated in .thymic 
animals ( . ) at all times (72 and 96 h; p :$ 0.001 for each). Values are the me"n TEWL (fold increase); baselinc TEWL is 1.02 mg per em2 per h. En'Ol' bnrs, 
SEM (n 2: 4). (13) T-ccll- cnriched imll'lune-cellreplenhhment restores UVB sensitivity in athymic mice. T hc elfect ofUVB on barrier fun ction was assessed 
in athymic animals receiving UVB alone (0 ) or UVB after replenishment with T -cell- enriched immune cells from previously irradiated dOllors (see Mafcri./; 
"lid Mer/wds) ( .). Values <Ire the mean TEWL (fold change); baseline TEWL is 1.08 mg pCI' cm1 per h. T-ce ll-rcplcnishcd animals regained UVB scnsirivicy 
and had a signiticantly elevated TEWL over UV-treated nonceplcnished animals, non-UV-trcatcd plus T-ccil-replenjshed "nim"ls (L:;), li nd non-UVB-tl'eatcd 
controls (0 ) ('''p :$ 0.05 for each) :I t 72 and 96 h. E rror {)I1rS, SEM (n 2: 6 anil11:l ls for each point). 
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Figure 6 . Only UVB-treated utixed imutune cells restore UVB 
sensitivity to athyrnic nlicc. Mjxed inlI111111e ceUs were isolated and 
expanded as described (Mareri"ls ""d Metllods) fr0111 bo th l1on-UVB- and 
UVB- treated animals (hairless) . R ecipient athymic animals received injec-
nons o f vehicle aloue (i .e. , sterile phosphate-buffered saline) or immune 
cells from either non-UVB (UVE - ) or V VB-trea ted (UVB +) dono r 
animal s. Data arc reported as fold change in TEW L over baseline; baseline 
TEWL is 1.20 mg per cm' per h. Only ce ll s fj'om VVB-trea ted dono rs 
resto re d the VVE-induced barrie r ddcct (p < 0.0 1 and 0. 05 at 72 and 96 h, 
respect:i vely) . E n '()r bar,. , SEM (n = 6 animals fo r each treatment gro up). 
UVB at 48 h [L e., 1.5-fold inc!:e"se (p :oS 0.01) versos time 0]. 
Al though the level of DNA response in the replenished animals is 
not e quivalent to that in the hairless control animals, these results 
suggest that UVB induction m activation of T cells is in part 
responsible for the epidermal hyperplastic response after UVB . 
Finally, an epidermal hyperproliferative response also is known 
to o ccur after acute barrier disruption, during the later phase of 
permeability barriet· repair (i .e. , peak (JH] thymidine increase occurs 
between 18 and 20 h) (Proksch e( 01 , 1991b). Since the athymic 
animals lack a significant hyperplasia response to UVB, w e studied 
the b a rrier repair response in athymic verst/s hairless animals after 
acute acetone extraction of stratum corneum lipids . Athymic 
animals displayed a rate of banier repair (i.e., decreasing TEWL 
with time) equivalent to the immunocompetent hairless control 
animals (data no t shown) . Furthermore, nearly identical increases in 
th)'lnidine incorporation were observed for haidess (1 .6-fold) and 
athyrnic (1 .7-fold) animals 20 h afrer barrier disruption (Table II) . 
As n oted above, however, only reconstituted animals displayed the 
hypex:plasia response to UVB (Table II). Therefore, these results 
suggest that the mechanisms regulating epide!:J11al proliferation are 
distinct for these two models. 
The UVB-Induced Increase in PGEz and Corticoid-Respon-
sive Inflammatory Elements Are Not Associated with De-
velopment of the Barrier Abnormality Since exp osure of 
mammalian skin to UVB induces an inflammatory cascade, includ-
ing in creased PGE2 production (Black el ai, 1978, 1980) , w e next 
investigated whether PGE2 generation contributes to th e UVB 
alteration in barri er function. As observed in Fig 7A, a single UVB 
dose o f 7.5 MED indu ced a significant increase ill PGE2 levels in 
whole hairless m Ollse skin (i. e ., 3- to 4- fold increase over baselln e 
of 150 0 pg per cm2 ; p < 0.005), levels that remained elevated for 
at least 48 h after trea tm ent. TIllS UVB-induced increase in PGE, 
was blocked by topical pre-UVE (5 d before UVB) and post-uvB 
(daily) indomethacin (0.50 mg) treH tment (Fig 7A) (p < 0.005 at 6, 
24, and 48 h) . Although indomethacin blocked PGE2 production , it 
did not influence development of the UVB-induced barrier defect 
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(Fig 7 B) . Furthermore, topical corticosteroid treatmen t immedi-
ately after UVB with either 1.0% triamcinolon e (Fig 7C) or 1% 
corticosterone (data not shown), which decreased the density of the 
UVB-induced inflammatory infilu'a te (data n ot shown) , did nOt 
alter the UVB-indu ced barrier effect. T hese results show that 
neither the increased PGE2 levels that occur after U VE exposure 
nor glu cocorticoid-sensitive inflammatory responses participate in 
the UVB-induced banier abnormali ty. 
DISCUSSION 
R esearch in this and other laboratOl'ies over th e past two decades 
has fo cused on the structure and function of the epidermal perme-
abili~ barri~r (reviewed in Elias and M enon, 199 1). Permeabili ty 
barner reqwrements appear to !:egulate not OIl] y epidermal lip id 
synthesis (Menon elol, 1985; Holleran et nl, 19913) but also DNA 
synthesis and epidermal proliferation (Proksch et ai, 1991 b). Al-
though UVR is know n to damage the penneability batTier and to 
enhance percutaneous absorption (see llIlrodIlCl ioJJ), tb e mechanism 
of the UVB-indllced barrier disorder is not know n . H erein , we 
demonstrated first that the barrier alteration indu ced by UVB in 
hairless mice is bo th dose- and time-dependent, with a lag- time of 
ov~r 48 h. This delay in th e development of the barrier abnormality 
Itldlcates that the UVB effect on the barrier carulOt be attributed to 
a primary insul t to sU'atum corneum lamellar membrane structures, 
~s is the case witb solvents, sur£lctants, and tape stripping (reviewed 
111 Menon el ai, 1992), but rather depends upon cellular or 
met~boli c changes in underlyin g skin layers that induce a patho-
gemc cascade tbat leads eventually to barrier disrup tion. 
Since alterations in epidermal proliferation are known conse-
quences of acute UVl't (Epstein e/ ai, 1968, 1970), we next 
determined w hether increased DNA syndlesis is a prerequisite fo r 
the UVB-induced barrier defect. Peak DNA syn thesis was observed 
at 36 - 4~ h after UVB exposure , a time that precedes em ergence of 
dle barner defect, eliminating the possibility that hyperproliferation 
?ccllrs as a consequence of the barrier defect, as with other acute 
I11sults (Proksch ei nl, 1991 b). Indeed , our results suggest strongly 
~hat the hyperproliferative response is required fo !: the UVB-
mduced barrie!: defect. Inhibition of epidermal pro liferation, with 
three chemically unrelated inhibitors of DNA synthesis, diminish ed 
the effects of acute U VB e":posure on the barrier. Although these 
compounds inhibit epidermal p roliferation at the doses used for 
these studies, these data do not exclude sepal'ate or addition al 
effects o f these inh.ibitors on T cell s th at could subsequently alter 
the epidermal response (see below) . In eith er case, ul trastructural 
studies sugges t that epidenna] hyperproliferatioll after UVB accel-
Table II. Increases in DNA Synthesis After Either UVB 
Exposure (Experiment A) or Acetone-Barder Disrup tion 
(Experiment B)" 
Athymic 
Experiment Hairless N o nrecon stituted Reconstituted 
A After UVB 
Time 0 h" 274 :t 54 225 :t 17" 225 :t 17' 
Time 48 h 654 ::':: 158 254 ::':: 13 345 ::':: 42 
Fold change (11) 2.4 (4) 1.1 (5) 1. 5 (5) 
B A fte r a Cton e 
Time 0 h" 188 ::':: 42 151 ::':: 59 ND" 
T ime 20 h 306 :t 15 250 :t 10 NO 
Fold chnnge (n) 1.6 (4) 1.7 (4) ND 
~ , " Data :1rc the incorporation of thym id ine (di si l1 regr~tions per minu tt.! pe r m1crogr~nl 
0 1' DNA; me:", :!: SEM). 
/. Time 0 is before irr;ldiation. 
,. V~ IlI cs tor no n rcconstiturcd :ll1d rccollsti tllfc-d control (ti lll t.: 0) :I re trom d ie same 
pool of samples. 
,/ Time 0 is before acctoll c .. bnrri cr disru ption. 
(' ND, lI ot determ ined.. 
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Fig ure 7. E ffect of indomethacin on PGE2 and T EWL after UVB. H airless mice were treated with U VB at tim e 0 and l'eccived vehicle (O) Or 
anti-infl ammatory agen ts as described in Materials allri Mel/lOris. (A and B) Indomethacin , • . (C) Triamcinolone (1%), • . (A) Indomethacin , given pre- UVB 
(5 d) and post-UV13 (0.5 mg daily) significantly inhibited the UVB-induced increase in cutaneous PGE2 levels at 6, 24, and 48 h (p S O.OOS) . R esul ts are 
from one of three separate experiments. EI'I'O/' bars, SEM (n 2! 4). (B) Indomethacin had no elfeet on the increased TEWL ind uced by UVB. Resul ts are the 
mean fo ld increase in TEWL; base line TEWL is 1.20 mg per em 2 per h. Error bal'.f , SEM (11 ;;, 4). (C) Topical administration of either triamcinolone or 
corticosterone (data not shown) did not alter the UVB-induced ba rri er defect (i. e. , no change in TEWL). Values are the mean TE\V L; baseline TEWL il 
1. 20 mg per cm2 per h. EI1'Ot' bars, SEM (n 2! 4). 
erates delivery of a layer of damaged cells to the stratum corneum . I 
An tiproliferative agen ts, tben, would slow the migration of such a 
band of defective o r " barrier-incompetent" cells to th e outer 
epidermis, allowing sufricien t tim e fo r subj acent cells to compen-
sate with increased lipid producti on, a process that is up-regulated 
by UVB ill vivo (Wefers et ai, 1991; H olJ el'all W M et Il l, submitted) 
and in vitro. 2 Furtherm ore, aging murin e epidermis displays a 
diminished UVB-induced barrier defect that is linked to a reduced 
proli fe rative response (Haratake et aI , 1997) . T hus, these studies 
strongly suggest that epidermal hyperplasia is a key factor in the 
barrier defect induced by acute UVB exposure. 
Previolls studies from this laboratory have demonstrated that 
permeability barrier hOL11 eostasis is maintained by speci fi c metabolic 
processes (Men O il ct aI, 1985; Holl eran e/ aI, 1991a, 1. 993; Proksch 
el ai, 1.991a, 1991 b; Mao- Q iang et aI, 1995 ), including the produc-
tion and release ofspeciti c cytokin es (Wood e/ ai, 1992; Nickoloff 
and Naidu, 1994), induction of epidennallipid synthesis (Menon et 
aI, 1985; H olleran el aI, 1991.a) , enzymatic lipid processing (H olle-
ran et aI, 1993; Mao-Qiang e/ aI, 1995), and epidermal hyper-
proliferation (Proksch el aI, 1991 b). Although the extent of the 
increase in DN A synthesis is dependent upon the level of barrie r 
abrogation , it is not known whether the proli ferative response is 
required fo r normal rates of recovery. In the current study, the 
barrier defec t induced by UYE is preceded by a hyperpro Li fera tive 
response, and it is clear that this response is transiently deleterious 
rather than restora tive to normal bar rier function . Yet, both the 
homeostatic and the UVB-induced prolifera tive responses may 
utilize common signaling mechanisms. D uring the permeability 
barrier recovery after acute insults , mitogenic cytokines and growth 
factors are generated by the epidermis including tUl110r necrosis 
factor a, TGFa, interleukin (IL)-l a , IL- 6, and lL-8 (Wood et aI, 
1992; Nicko loff and N aidu, 1994), as well as amphiregulin and 
ner ve growth fac tor (Liou et ai, 1997) . Cytokines genera ted by 
dermal elements andlor inflanunatory cell s also may participate in 
the recovery process (Nickoloff and N aidll , 1994). Likewise, DVB 
exposure also generates a well-established cytokin e resp onse in the 
epidermis, incl uding increased produ ction of tumor necrosis fac tor 
a, IL-1 , IL- 6, and IL-8 (Kupper e/ ai, 1987; Oxholm et aI , 1988; 
Schwarz and Luger, 1989; Kondo et ai, 1994). Th erefore, although 
the in.itiating stimuli differ, the hyperplasia induced both by barrier 
disruption and U YE may OCCllI' in response to similar mi togenic 
cytokines. Beca use athymic animals recover fro m acute barrier 
injury and displ ay an epidermal h yperplasia resp onse, however, the 
I Uchida Y, Holleran W M, Halkier-Sorcnscn L, Hara M, T hestrup-
Pedersen K, EI.ias PM: Ult..,lstfll ctural basis fo r the U VB-induccd abnormal-
ity in barrier function. ) ]west DCI'JIl ato/ 108:643, 1997 (abstr). 
2 Farrell A, Nagi"c MM. Dickson R C , ELias PM, Ho ller'111 W M : UVB 
upregu/.arcs serine palmitoyl ' transferase in cultured human keratinocytcs. 
J [lIl /es t Denll ato/ 106:873, 1996 (abstr). 
DVB-induced response appears distinct and sugges ts th e involve-
ment of specifIC thymocyte-derived fac tors. 
A putative role fo r T cells in the UVB-induced barrier defect is 
supported by Ollr studies with both CsA-trea ted and athymic 
animals. A single dose of CsA (3 .0 mg) inhibits the development of 
barri er abnorm ali ties after an acute UVB exposure and inhibits the 
epidermal hyp erpl as tic response. CsA diminish es the ac tivation and 
migra ti on of T cells (Baker el ai, 1987; Gupta el ai, 1989), proposed 
as important mechanisms tlu'ough which CsA works for various 
derm3tologic disorders (Ellis el ai, 1986; Powles r/ ai, 1988; Ho e/ al 
1990). CsA, however, also redu ces IL- 1C/, tumor necrosis factor a, 
and IL- 6 gene expression in murine epidermis (Won et aI, 1994; 
Kono ct ai, 1995) and inhibits keratin ocyte proli fe ration (Fisher et al 
1988; Furue el nl, 1988; Nickoloff el ai, 1988; R amil'ez-Bosca e/ ai, 
1990). T he present studies did not address whether one or more of 
the above mechanisms accoun ted for th e CsA effect on the 
D VB-induced barrier abnormality. H ence, we also performed 
additional studies in athymic mice that poin t cl earl y to a role for 
thYl110cytes in the DYE-induced barrier defect. T he diminished 
response in ath ymic mice, which lack a competent T -ceJl popula-
tiOIl , and the re-esW blishment of UVB sensitivity in athymic mic~ 
transplanted wi th T-cell- enrich ed mixed immune cells st.rongly 
suggest that either T cells themselves or a soluble thymocyte-
derived cytokine(s) is (are) important contributors to the barrier 
defect. Although thymocyte-induced epidermal hyperplasia appears 
to be involved, the mechanism(s) by w hich T cells contribute to 
th.is process requires fu rther in ves tigation . Furthermore, because 
only mixed immune cells from i'Tadiated-donor mice res tored a 
normal barrier response , D VB must be directly altering these cell . 
Because DYE induces cutaneo us inflammation, we also investi-
ga ted the ro le of inflamm ation in the UVB-induced barrier clisrup-
tion . We showed, as have o thers (Black et Ill , 1978, 1980), that 
U YE induces an in crease in cutaneous PGE2 levels, sugges ting a 
possible ro le for PGE2 in the DYE-induced hyperplasia. Indeed, 
PGEz levels are eleva ted in proliferating cu]tllred human keratino-
cytes, and the cyclooxygenase inhibi tor indom ethacin reduces both 
endogenous PGE2 production and keratinocyte pro lifera tion (Pent-
land et aI, 1986 , 1987). In addition, pre- treatment of immortalized 
human lens epithelial cells with indomethacin attenuates the UVB-
induced increases in both PGE2 levels and hyperproliferation 
(And ley et ai, 1996). Yet, indometh acin blockade of the UVB-
indu ced increase in cutaneo us PGE2 levels did no t interfere with 
development of the permeability barrier abnormality. Moreover, 
co-application of topica l corticosteroids, pharmacologic agents with 
broad anti- inflammatory effects, also did no t diminish the UVB-
indu ced barrier alterations. These res ul ts indicate that a nonspecifir 
inflam matory response is no t responsible fo r the U VB-induced 
barrier abnormality. 
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